肌萎缩
医学
健康福利
儿茶素
骨骼肌
绿茶
临床试验
生物信息学
多酚
传统医学
生物
内科学
生物化学
食品科学
抗氧化剂
作者
Taotao Wang,Hong Xu,Shanshan Wu,Yuanxin Guo,Guangshan Zhao,Dongxu Wang
标识
DOI:10.1021/acs.jafc.3c02023
摘要
Sarcopenia is prevalent among the older population and severely affects human health. Tea catechins may benefit for skeletal muscle performance and protect against secondary sarcopenia. However, the mechanisms underlying their antisarcopenic effect are still not fully understood. Despite initial successes in animal and early clinical trials regarding the safety and efficacy of (−)-epigallocatechin-3-gallate (EGCG), a major catechin of green tea, many challenges, problems, and unanswered questions remain. In this comprehensive review, we discuss the potential role and underlying mechanisms of EGCG in sarcopenia prevention and management. We thoroughly review the general biological activities and general effects of EGCG on skeletal muscle performance, EGCG's antisarcopenic mechanisms, and recent clinical evidence of the aforesaid effects and mechanisms. We also address safety issues and provide directions for future studies. The possible concerted actions of EGCG indicate the need for further studies on sarcopenia prevention and management in humans.
科研通智能强力驱动
Strongly Powered by AbleSci AI